Background Low skeletal muscle mass (LSMM) and/or, function associated with an
increased risk of treatment‐related toxicities and inferior overall survival (OS) among adults …

Background & aims The purpose of this meta-analysis was to summarize the published data
regarding associations between occurrence of severe treatment related toxicity and low …

Objectives Low skeletal muscle mass (LSMM) predicts relevant clinical outcomes in
oncologic patients. The purpose of this study was to perform a meta-analysis of data …

Background The correlation between sarcopenia and hematological malignancy prognosis
is still controversial. Design: A systematic review and meta-analysis. Objectives: To explore …

Background Body composition plays an important role in predicting treatment outcomes in
adults with cancer. Using existing computed tomographic (CT) cross-sectional imaging and …

Low skeletal muscle mass is known to be associated with poor morbidity and mortality
outcomes in cancer, but evidence of its impact on health‐related quality of life (HRQOL) is …

Objectives Individuals with prior cancer diagnosis are more likely to have low muscle mass
(LMM) than their cancer-free counterparts. Understanding the effects of LMM on the …

Low skeletal muscle mass (LSMM) is increasingly recognized for its predictive value for
adverse events in cancer patients. In specific, the predictive value of LSMM has been …

Background Low muscle mass (MM) is a common component of cancer‐related malnutrition
and sarcopenia, conditions that are all independently associated with an increased risk of …

Both quality and quantity of skeletal muscle are considered important for prognostic factors
and clinical outcomes in solid cancers. However, few studies have examined both quality …